TBL1X Activators

The term TBL1X Activators refers to a set of compounds that can indirectly influence the activity of TBL1X. These compounds are not direct activators of TBL1X but can affect cellular processes and molecular pathways in which TBL1X is involved. For instance, retinoic acid and thyroid hormone can influence the transcriptional activities of the NCoR complex, where TBL1X is a component. Similarly, glucocorticoids like dexamethasone and glucocorticoid receptor antagonists like mifepristone can interfere with NCoR complex functions, potentially affecting TBL1X. AlF4-, on the other hand, binds to GTP-binding proteins in a way that induces a transition state, causing these proteins to remain active.

Other compounds, like GW3965 and GSK2033, can affect the NCoR complex by acting as agonists or antagonists of liver X receptors (LXRs), thereby influencing TBL1X. Histone deacetylase inhibitors like trichostatin A and SAHA can also interact with the NCoR complex and potentially affect TBL1X functions. Additionally, compounds like curcumin and resveratrol can disrupt or influence the NCoR complex, thereby indirectly affecting TBL1X. These compounds include hormones (retinoic acid and T3), glucocorticoids (dexamethasone), glucocorticoid antagonists (mifepristone), histone deacetylase inhibitors (Trichostatin A, Vorinostat), curcumin and resveratrol that can disrupt or modulate the NCoR complex, and compounds that influence the activity of bromodomains (JQ1, I-BET151) or liver X receptors (GW3965, GSK2033). Lastly, BRD4 inhibitors like JQ1 and I-BET151 can interact with the NCoR complex and potentially influence TBL1X. Therefore, while these compounds do not directly activate TBL1X, their influence on the NCoR complex can indirectly affect TBL1X functions.